Lihui Yu is Senior Director of Commercial Quality at Johnson & Johnson Innovative Medicine, Asia Pacific and a member of the Asia Pacific Leadership Team.
With more than 20 years of experience in pharmaceutical quality and compliance, Lihui has a proven track record of strong leadership and talent development in roles spanning active pharmaceutical ingredient (API) and drug product manufacturing, commercial launch, product distribution, and post-market surveillance. She excels in leading local, regional, and global initiatives, promoting innovation through advanced tools and technologies, and ensuring compliance with quality systems and regulatory requirements.
In her recent role as China Commercial Quality Head, Lihui achieved notable successes, including designing a digital transformation roadmap, ensuring patient access to medication during epidemics, influencing regulatory revisions, and leading the China Advancement Plan program.
Now based in Singapore, Lihui leads the APAC regional Commercial Quality team.
Outside of work, she enjoys spending time with her husband, 14-year-old son, and parents.